Enveda Therapeutics
Clinical trials sponsored by Enveda Therapeutics, explained in plain language.
-
New asthma pill aims to tame breathing trouble
Disease control Recruiting nowThis study tests an experimental oral drug, ENV-294, in 50 adults with moderate-to-severe asthma who already use standard inhalers. Participants take either the drug or a placebo once daily for 12 weeks. Researchers will check safety, drug levels, and whether the pill improves as…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:25 UTC
-
New eczema pill shows promise in early trial
Symptom relief Recruiting nowThis study tests a new daily pill, ENV-294, in 60 adults with moderate-to-severe eczema (atopic dermatitis) who haven't had success with creams. For 12 weeks, participants take either the drug or a placebo and visit the clinic regularly to track skin improvement and any side effe…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC